Company Overview of Icon Bioscience Inc.
Icon Bioscience Inc., a biopharma company, develops and commercializes intraocular ophthalmic products based on its Verisome drug delivery technology. Its products target various ophthalmic indications, including glaucoma, macular edema, inflammation/infection associated with cataract surgery, and age-related macular degeneration. The company was incorporated in 2004 and is based in Sunnyvale, California.
1253 Reamwood Avenue
Sunnyvale, CA 94089
Founded in 2004
Key Executives for Icon Bioscience Inc.
Icon Bioscience Inc. Key Developments
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Icon Bioscience Inc., please visit iconbioscience.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.